Correction to J&J Actelion Story
15 June 2017 - 5:51AM
Dow Jones News
"J&J Plans to Add Drug Discovery and Early Research to
Actelion Unit," at 1:05 p.m. EDT, incorrectly stated that J&J's
initial stake would be 16% in the final paragraph. A J&J
subsidiary initially will hold a 9.9% stake in the new company,
with an option to increase this to 32% in the future. (June 14)
(END) Dow Jones Newswires
June 14, 2017 15:36 ET (19:36 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024